
|Videos|January 22, 2019
Perioperative Immunotherapy the Future of HCC Treatment?
Author(s)Ahmed Kaseb, MD
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Advertisement
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
How Did Daraxonrasib Double Survival in Pretreated Metastatic Pancreatic Cancer?
2
Analyzing the Role of CELMoDs in the Relapsed/Refractory Myeloma Space
3
Tebentafusp Yields Favorable 5-Year OS Data in HLA-A*02:01+ Uveal Melanoma
4
Belantamab Mafodotin Combo for R/R Multiple Myeloma Earns Approval in China
5

























































